Immediate and Long-Term Effects of an 8-Week Digital Mental Health Intervention on Adults With Poorly Managed Type 2 Diabetes: Protocol for a Randomized Controlled Trial

Eliane Boucher, Judith T Moskowitz, Gina M Kackloudis, Julia L Stafford, Ian Kwok, Acacia C Parks, Eliane Boucher, Judith T Moskowitz, Gina M Kackloudis, Julia L Stafford, Ian Kwok, Acacia C Parks

Abstract

Background: Diabetes is a leading cause of years of life lost and accounts for approximately one-fourth of health care dollars spent in the United States. Many of these costs are related to poor medication adherence and lack of self-care behaviors and are thus preventable. Depression, which is more prevalent among people with diabetes than in the general population, predicts poorer management of one's diabetes, whereas positive affect predicts engaging in more positive health behaviors. Consequently, interventions that improve depression and positive affect may also improve diabetes-related outcomes among people with diabetes. Although preliminary research on the impact of such interventions among people with diabetes is promising, these studies focused primarily on in-person interventions, have had small samples, and lack long-term follow-up.

Objective: This study aims to examine the short- and long-term effects of a digital therapeutic platform focused on mental health among adults with poorly managed type 2 diabetes and elevated levels of depression.

Methods: This is a randomized controlled trial in which adults with a type 2 diabetes diagnosis, elevated hemoglobin A1c (HbA1c) levels (≧7), and moderate to severe depressive symptoms will be randomly assigned to a positive emotion regulation skills intervention group or a sham digital intervention with only psychoeducational content. The study will take place over 14 months, including the 8-week intervention (or control) delivered via a digital therapeutic platform (Happify Health) and follow-up assessments at 3, 6, and 12 months postintervention. Throughout the intervention and for 1 week at each postintervention follow-up, participants will complete daily assessments of diabetes-related distress, diabetes regimen adherence, and mood. Our primary outcome, HbA1c, will be self-reported every 3 months throughout the study. Secondary and exploratory outcomes will be assessed at baseline; at 8 weeks; and at 3, 6, and 12 months postintervention.

Results: Recruitment is expected to begin in June 2020. Participants will begin the study as they are recruited and will finish in waves. The final wave of data collection from the 8-week intervention is expected for winter 2020, with the completion of the 12-month follow-up in winter 2021.

Conclusions: Although previous research suggests that in-person psychological interventions have promising effects on both psychological and physical outcomes among adults with diabetes, digital interventions can be advantageous because they are easily scalable and reduce many barriers that prevent people from seeking treatment. This trial will provide important information about the effects of a digital mental health intervention among adults with type 2 diabetes, assessing both short- and long-term effects of this intervention on HbA1c, depressive symptoms, and other diabetes-specific outcomes. If successful, this may introduce a scalable intervention that would help reduce some of the preventable costs associated with diabetes.

Trial registration: ClinicalTrials.gov NCT04068805; https://ichgcp.net/clinical-trials-registry/NCT04068805.

International registered report identifier (irrid): PRR1-10.2196/18578.

Keywords: HbA1c; diabetes mellitus; mental health; online intervention; positive psychology; randomized clinical trial; type 2.

Conflict of interest statement

Conflicts of Interest: EB, GK, JS, and AP are employees of Happify Health.

©Eliane Boucher, Judith T Moskowitz, Gina M Kackloudis, Julia L Stafford, Ian Kwok, Acacia C Parks. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 04.08.2020.

Figures

Figure 1
Figure 1
Screenshot of the featured track description for Developing Affective HeaLth to Improve Adherence intervention.
Figure 2
Figure 2
Screenshot of the track description in sham digital intervention.

References

    1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011 Dec;94(3):311–21. doi: 10.1016/j.diabres.2011.10.029.
    1. GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016 Oct 8;388(10053):1459–544. doi: 10.1016/S0140-6736(16)31012-1.
    1. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. J Am Med Assoc. 2015 Sep 8;314(10):1021–9. doi: 10.1001/jama.2015.10029.
    1. Centers for Disease Control and Prevention. 2020. [2020-01-27]. National Diabetes Statistics Report 2020: Estimates of Diabetes and Its Burden in the United States .
    1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047–53. doi: 10.2337/diacare.27.5.1047.
    1. Riddle MC, Herman WH. The cost of diabetes care-an elephant in the room. Diabetes Care. 2018 May;41(5):929–32. doi: 10.2337/dci18-0012.
    1. American Diabetes Association Economic costs of diabetes in the US in 2017. Diabetes Care. 2018 May;41(5):917–28. doi: 10.2337/dci18-0007.
    1. Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, Bärnighausen T, Davies J, Vollmer S. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018 May;41(5):963–70. doi: 10.2337/dc17-1962.
    1. Rubens M, Saxena A, Ramamoorthy V, Khera R, Hong J, Veledar E, Nasir K. Trends in diabetes-related preventable hospitalizations in the US, 2005-2014. Diabetes Care. 2018 May;41(5):e72–3. doi: 10.2337/dc17-1942.
    1. Shrestha SS, Zhang P, Hora I, Geiss LS, Luman ET, Gregg EW. Factors contributing to increases in diabetes-related preventable hospitalization costs among US adults during 2001-2014. Diabetes Care. 2019 Jan;42(1):77–84. doi: 10.2337/dc18-1078.
    1. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004 May;27(5):1218–24. doi: 10.2337/diacare.27.5.1218.
    1. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006 Sep 25;166(17):1836–41. doi: 10.1001/archinte.166.17.1836.
    1. Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ. 2004;30(1):112–25. doi: 10.1177/014572170403000119.
    1. Jerant AF, von Friederichs-Fitzwater MM, Moore M. Patients' perceived barriers to active self-management of chronic conditions. Patient Educ Couns. 2005 Jun;57(3):300–7. doi: 10.1016/j.pec.2004.08.004.
    1. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006 Nov;23(11):1165–73. doi: 10.1111/j.1464-5491.2006.01943.x.
    1. Strandberg RB, Graue M, Wentzel-Larsen T, Peyrot M, Rokne B. Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with HbA1c in adult persons with type 1 diabetes. J Psychosom Res. 2014 Sep;77(3):174–9. doi: 10.1016/j.jpsychores.2014.06.015.
    1. Leyva B, Zagarins SE, Allen NA, Welch G. The relative impact of diabetes distress vs depression on glycemic control in hispanic patients following a diabetes self-management education intervention. Ethn Dis. 2011;21(3):322–7.
    1. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000 Nov 27;160(21):3278–85. doi: 10.1001/archinte.160.21.3278.
    1. Mai Q, Holman CD, Sanfilippo FM, Emery JD. The impact of mental illness on potentially preventable hospitalisations: a population-based cohort study. BMC Psychiatry. 2011 Oct 10;11:163. doi: 10.1186/1471-244X-11-163.
    1. Lloyd CE, Pambianco G, Orchard T. Does diabetes-related distress explain the presence of depressive symptoms and/or poor self-care in individuals with type 1 diabetes? Diabet Med. 2010 Feb;27(2):234–7. doi: 10.1111/j.1464-5491.2009.02896.x.
    1. Moskowitz JT, Epel ES, Acree M. Positive affect uniquely predicts lower risk of mortality in people with diabetes. Health Psychol. 2008 Jan;27(1S):S73–82. doi: 10.1037/0278-6133.27.1.S73.
    1. Cohn MA, Pietrucha ME, Saslow LR, Hult JR, Moskowitz JT. An online positive affect skills intervention reduces depression in adults with type 2 diabetes. J Posit Psychol. 2014 Jan 1;9(6):523–34. doi: 10.1080/17439760.2014.920410.
    1. Robertson SM, Stanley MA, Cully JA, Naik AD. Positive emotional health and diabetes care: concepts, measurement, and clinical implications. Psychosomatics. 2012;53(1):1–12. doi: 10.1016/j.psym.2011.09.008.
    1. Strine TW, Chapman DP, Balluz LS, Moriarty DG, Mokdad AH. The associations between life satisfaction and health-related quality of life, chronic illness, and health behaviors among US community-dwelling adults. J Community Health. 2008 Feb;33(1):40–50. doi: 10.1007/s10900-007-9066-4.
    1. Grant N, Wardle J, Steptoe A. The relationship between life satisfaction and health behavior: a cross-cultural analysis of young adults. Int J Behav Med. 2009;16(3):259–68. doi: 10.1007/s12529-009-9032-x.
    1. Ferrari M, Dal Cin M, Steele M. Self-compassion is associated with optimum self-care behaviour, medical outcomes and psychological well-being in a cross-sectional sample of adults with diabetes. Diabet Med. 2017 Nov;34(11):1546–53. doi: 10.1111/dme.13451.
    1. Neff KD. The development and validation of a scale to measure self-compassion. Self Identity. 2003 Jul;2(3):223–50. doi: 10.1080/15298860309027.
    1. Piette JD, Richardson C, Valenstein M. Addressing the needs of patients with multiple chronic illnesses: the case of diabetes and depression. Am J Manag Care. 2004 Feb;10(2 Pt 2):152–62.
    1. Bolier L, Haverman M, Westerhof GJ, Riper H, Smit F, Bohlmeijer E. Positive psychology interventions: a meta-analysis of randomized controlled studies. BMC Public Health. 2013 Feb 8;13:119. doi: 10.1186/1471-2458-13-119.
    1. Massey CN, Feig EH, Duque-Serrano L, Wexler D, Moskowitz JT, Huffman JC. Well-being interventions for individuals with diabetes: a systematic review. Diabetes Res Clin Pract. 2019 Jan;147:118–33. doi: 10.1016/j.diabres.2018.11.014.
    1. Bogusch LM, O'Brien WH. The effects of mindfulness-based interventions on diabetes-related distress, quality of life, and metabolic control among persons with diabetes: a meta-analytic review. Behav Med. 2019;45(1):19–29. doi: 10.1080/08964289.2018.1432549.
    1. Guo J, Wang H, Luo J, Guo Y, Xie Y, Lei B, Wiley J, Whittemore R. Factors influencing the effect of mindfulness-based interventions on diabetes distress: a meta-analysis. BMJ Open Diabetes Res Care. 2019;7(1):e000757. doi: 10.1136/bmjdrc-2019-000757.
    1. Snoek FJ, van der Ven NC, Twisk JW, Hogenelst MH, Tromp-Wever AM, van der Ploeg HM, Heine RJ. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial. Diabet Med. 2008 Nov;25(11):1337–42. doi: 10.1111/j.1464-5491.2008.02595.x.
    1. Safren SA, Gonzalez JS, Wexler DJ, Psaros C, Delahanty LM, Blashill AJ, Margolina AI, Cagliero E. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care. 2014;37(3):625–33. doi: 10.2337/dc13-0816.
    1. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1998 Oct 15;129(8):613–21. doi: 10.7326/0003-4819-129-8-199810150-00005.
    1. Li C, Xu D, Hu M, Tan Y, Zhang P, Li G, Chen L. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for patients with diabetes and depression. J Psychosom Res. 2017 Apr;95:44–54. doi: 10.1016/j.jpsychores.2017.02.006.
    1. Mojtabai R, Olfson M, Sampson NA, Jin R, Druss B, Wang PS, Wells KB, Pincus HA, Kessler RC. Barriers to mental health treatment: results from the national comorbidity survey replication. Psychol Med. 2011 Aug;41(8):1751–61. doi: 10.1017/S0033291710002291.
    1. Conner KO, Copeland VC, Grote NK, Koeske G, Rosen D, Reynolds CF, Brown C. Mental health treatment seeking among older adults with depression: the impact of stigma and race. Am J Geriatr Psychiatry. 2010 Jun;18(6):531–43. doi: 10.1097/JGP.0b013e3181cc0366.
    1. Thomas KC, Ellis AR, Konrad TR, Holzer CE, Morrissey JP. County-level estimates of mental health professional shortage in the United States. Psychiatr Serv. 2009 Oct;60(10):1323–8. doi: 10.1176/ps.2009.60.10.1323.
    1. Warmerdam L, Smit F, van Straten A, Riper H, Cuijpers P. Cost-utility and cost-effectiveness of internet-based treatment for adults with depressive symptoms: randomized trial. J Med Internet Res. 2010 Dec 19;12(5):e53. doi: 10.2196/jmir.1436.
    1. Ferwerda M, van Beugen S, van Burik A, van Middendorp H, de Jong EM, van de Kerkhof PC, van Riel PL, Evers AW. What patients think about e-health: patients' perspective on internet-based cognitive behavioral treatment for patients with rheumatoid arthritis and psoriasis. Clin Rheumatol. 2013 Jun;32(6):869–73. doi: 10.1007/s10067-013-2175-9.
    1. Gerhards SA, Abma TA, Arntz A, de Graaf LE, Evers SM, Huibers MJ, Widdershoven GA. Improving adherence and effectiveness of computerised cognitive behavioural therapy without support for depression: a qualitative study on patient experiences. J Affect Disord. 2011 Mar;129(1-3):117–25. doi: 10.1016/j.jad.2010.09.012.
    1. van Bastelaar K, Cuijpers P, Pouwer F, Riper H, Snoek FJ. Development and reach of a web-based cognitive behavioural therapy programme to reduce symptoms of depression and diabetes-specific distress. Patient Educ Couns. 2011 Jul;84(1):49–55. doi: 10.1016/j.pec.2010.06.013.
    1. Beratarrechea A, Lee AG, Willner JM, Jahangir E, Ciapponi A, Rubinstein A. The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review. Telemed J E Health. 2014 Jan;20(1):75–82. doi: 10.1089/tmj.2012.0328.
    1. Andersson G, Titov N. Advantages and limitations of internet-based interventions for common mental disorders. World Psychiatry. 2014 Feb;13(1):4–11. doi: 10.1002/wps.20083. doi: 10.1002/wps.20083.
    1. Wang Y, Xue H, Huang Y, Huang L, Zhang D. A systematic review of application and effectiveness of mhealth interventions for obesity and diabetes treatment and self-management. Adv Nutr. 2017 May;8(3):449–62. doi: 10.3945/an.116.014100.
    1. Hadjiconstantinou M, Byrne J, Bodicoat DH, Robertson N, Eborall H, Khunti K, Davies MJ. Do web-based interventions improve well-being in type 2 diabetes? A systematic review and meta-analysis. J Med Internet Res. 2016 Oct 21;18(10):e270. doi: 10.2196/jmir.5991.
    1. Quinn CC, Swasey KK, Crabbe JC, Shardell MD, Terrin ML, Barr EA, Gruber-Baldini AL. The impact of a mobile diabetes health intervention on diabetes distress and depression among adults: secondary analysis of a cluster randomized controlled trial. JMIR Mhealth Uhealth. 2017 Dec 7;5(12):e183. doi: 10.2196/mhealth.8910.
    1. van Bastelaar KM, Pouwer F, Cuijpers P, Riper H, Snoek FJ. Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 2011 Feb;34(2):320–5. doi: 10.2337/dc10-1248.
    1. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York, USA: Guilford Press; 1979.
    1. Praissman S. Mindfulness-based stress reduction: a literature review and clinician's guide. J Am Acad Nurse Pract. 2008 Apr;20(4):212–6. doi: 10.1111/j.1745-7599.2008.00306.x.
    1. Sin NL, Lyubomirsky S. Enhancing well-being and alleviating depressive symptoms with positive psychology interventions: a practice-friendly meta-analysis. J Clin Psychol. 2009 May;65(5):467–87. doi: 10.1002/jclp.20593.
    1. Schueller SM, Parks AC. Disseminating self-help: positive psychology exercises in an online trial. J Med Internet Res. 2012 Jun 25;14(3):e63. doi: 10.2196/jmir.1850.
    1. Seligman ME, Steen TA, Park N, Peterson C. Positive psychology progress: empirical validation of interventions. Am Psychol. 2005;60(5):410–21. doi: 10.1037/0003-066X.60.5.410.
    1. Chambless DL, Hollon SD. Defining empirically supported therapies. J Consult Clin Psychol. 1998 Feb;66(1):7–18. doi: 10.1037//0022-006x.66.1.7.
    1. Sheldon KM, Elliot AJ. Goal striving, need satisfaction, and longitudinal well-being: the self-concordance model. J Pers Soc Psychol. 1999 Mar;76(3):482–97. doi: 10.1037//0022-3514.76.3.482.
    1. Carpenter J, Crutchley P, Zilca RD, Schwartz HA, Smith LK, Cobb AM, Parks AC. Seeing the 'big' picture: big data methods for exploring relationships between usage, language, and outcome in internet intervention data. J Med Internet Res. 2016 Aug 31;18(8):e241. doi: 10.2196/jmir.5725.
    1. Carpenter J, Crutchley P, Zilca RD, Schwartz HA, Smith LK, Cobb AM, Parks AC. Correction: seeing the 'big' picture: big data methods for exploring relationships between usage, language, and outcome in internet intervention data. J Med Internet Res. 2017 Dec 19;19(12):e347. doi: 10.2196/jmir.8099.
    1. Parks AC, Williams AL, Tugade MM, Hokes KE, Honomichl RD, Zilca RD. Testing a scalable web and smartphone based intervention to improve depression, anxiety, and resilience: a randomized controlled trial. Int J Wellbeing. 2018 Dec 8;8(2):22–67. doi: 10.5502/ijw.v8i2.745.
    1. Williams AL, Parks AC, Cormier G, Stafford J, Whillans A. Improving resilience among employees high in depression, anxiety, and workplace distress. Int J Manag Res. 2018;9(1-2):4–22.
    1. Parks AC, Williams AL, Kackloudis GM, Stafford JL, Boucher EM, Honomichl RD. The effects of a digital well-being intervention on patients with chronic conditions: observational study. J Med Internet Res. 2020 Jan 10;22(1):e16211. doi: 10.2196/16211.
    1. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals. 2002 Sep 1;32(9):509–15. doi: 10.3928/0048-5713-20020901-06.
    1. American Diabetes Association Glycemic targets: standards of medical care in diabetes-2019. Diabetes Care. 2019 Jan;42(Suppl 1):S61–70. doi: 10.2337/dc19-S006.
    1. van Son J, Nyklíček I, Pop VJ, Blonk MC, Erdtsieck RJ, Pouwer F. Mindfulness-based cognitive therapy for people with diabetes and emotional problems: long-term follow-up findings from the DiaMind randomized controlled trial. J Psychosom Res. 2014 Jul;77(1):81–4. doi: 10.1016/j.jpsychores.2014.03.013.
    1. Kopf S, Oikonomou D, Hartmann M, Feier F, Faude-Lang V, Morcos M, Häring HU, Herzog W, Bierhaus A, Humpert PM, Nawroth PP. Effects of stress reduction on cardiovascular risk factors in type 2 diabetes patients with early kidney disease - results of a randomized controlled trial (HEIDIS) Exp Clin Endocrinol Diabetes. 2014 Jun;122(6):341–9. doi: 10.1055/s-0034-1372583.
    1. Eysenbach G. The law of attrition. J Med Internet Res. 2005 Mar 31;7(1):e11. doi: 10.2196/jmir.7.1.e11.
    1. Christensen H, Griffiths KM, Farrer L. Adherence in internet interventions for anxiety and depression. J Med Internet Res. 2009 Apr 24;11(2):e13. doi: 10.2196/jmir.1194.
    1. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, Jackson RA. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005 Mar;28(3):626–31. doi: 10.2337/diacare.28.3.626.
    1. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan;24(1):67–74. doi: 10.1097/00005650-198601000-00007.
    1. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000 Jul;23(7):943–50. doi: 10.2337/diacare.23.7.943.
    1. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, Ader D, Fries JF, Bruce B, Rose M, PROMIS Cooperative Group The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007 May;45(5 Suppl 1):S3–11. doi: 10.1097/01.mlr.0000258615.42478.55.
    1. Starr LR, Davila J. Temporal patterns of anxious and depressed mood in generalized anxiety disorder: a daily diary study. Behav Res Ther. 2012 Feb;50(2):131–41. doi: 10.1016/j.brat.2011.11.005.
    1. Diener E, Seligman ME. Very happy people. Psychol Sci. 2002 Jan;13(1):81–4. doi: 10.1111/1467-9280.00415.
    1. Mehl MR, Vazire S, Holleran SE, Clark CS. Eavesdropping on happiness: well-being is related to having less small talk and more substantive conversations. Psychol Sci. 2010 Apr;21(4):539–41. doi: 10.1177/0956797610362675.
    1. Lewandowski AS, Palermo TM, Kirchner HL, Drotar D. Comparing diary and retrospective reports of pain and activity restriction in children and adolescents with chronic pain conditions. Clin J Pain. 2009 May;25(4):299–306. doi: 10.1097/AJP.0b013e3181965578.
    1. Murphy ME, Byrne M, Galvin R, Boland F, Fahey T, Smith SM. Improving risk factor management for patients with poorly controlled type 2 diabetes: a systematic review of healthcare interventions in primary care and community settings. BMJ Open. 2017 Aug 4;7(8):e015135. doi: 10.1136/bmjopen-2016-015135.
    1. Kazdin AE. Clinical psychological science editorial. Clin Psychol Sci. 2013 Nov 15;2(1):3–5. doi: 10.1177/2167702613514513.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться